Published November 2016 | Version v1
Journal article

Efficacy of palliative radiation therapy for symptomatic rectal cancer

  • 1. Department of Radiation Oncology, Tan Tock Seng Hospital, National Cancer Institute of Singapore (Singapore)
  • 2. Department of Radiation Oncology, National University Hospital, National Cancer Institute of Singapore (Singapore)
  • 3. National Registry of Diseases Office, Health Promotion Board (Singapore)

Description

99 patients with symptomatic locally advanced rectal cancer who were treated with palliative radiation alone were reviewed. Dose-fractionation ranged from 18 to 54 Gy. Response rate ranged from 62.5 to 86.7%, with a median response duration ranging 4.2–5.4 months. Median survival was 6.9 months. Using a BED cut-off of 39Gy10, no dose–response relationship was found.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2016.06.023

Additional details

Identifiers

DOI
10.1016/j.radonc.2016.06.023;
PII
S0167814016343079;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
121
Journal Issue
2
Journal Page Range
p. 258-261
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51004938
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
FRACTIONATED IRRADIATION; NEOPLASMS; PATIENTS; RADIOTHERAPY; RECTUM; THERAPEUTIC DOSES
Descriptors DEC
BODY; DIGESTIVE SYSTEM; DISEASES; DOSES; GASTROINTESTINAL TRACT; INTESTINES; IRRADIATION; LARGE INTESTINE; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.